Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Promising phase III results reported for KeraVision ring

Nov. 4, 1997

German launch for Xalatan

Oct. 23, 1997

Patient recruitment for verteporfin phase III trials exceeds goals

Sep. 30, 1997

Lotemax deemed approvable by FDA

Sep. 26, 1997

Angiogenesis inhibitors described by Janssen

Sep. 25, 1997

AEterna initiates phase I trial in AMD

Sep. 24, 1997

Axokine use in retinal degeneration covered in new patent

Sep. 23, 1997

Initial phase III results reported for KeraVision Ring

Sep. 17, 1997

AMO Array Multifocal IOL approved for marketing in U.S.

Sep. 11, 1997

Tolmetin eyedrop formulation evaluated in rabbits

Sep. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...